Vanberra Signal

Aleva Neuro

Curated by Signal

Develops implantable deep brain stimulation systems that enables therapies for neurological diseases

Overview

Aleva Neurotherapeutics has developed a MEMS technology backed neurostimulation platform, which is based on micro deep brain stimulation technology that enables therapies for neurological diseases. They are primarily targeting indications such as parkinsonʼs disease and Essential Tremor. They have developed directSTIM™ DBS (Deep Brain Stimulation) System - an implantable deep brain stimulation systems; spiderSTIM™ DBS Diagnostic System.

Key facts

Founded
2008

Business model

Contact

More on Vanberra Signal

Members only

Competitors & similar companies

More High Technology companies
  • Provider of layer 1 blockchain protocol

    High TechnologyLugano, Switzerland
  • Provider of smart textiles for remote health monitoring

    High TechnologyZurich, Switzerland
  • Provider of an AI-based platform for building and deploying machine learning models

    High TechnologySwitzerland

About Aleva Neuro

What does Aleva Neuro do?

Aleva Neurotherapeutics has developed a MEMS technology backed neurostimulation platform, which is based on micro deep brain stimulation technology that enables therapies for neurological diseases.

Where is Aleva Neuro headquartered?

Aleva Neuro is headquartered in Lausanne, Switzerland.

When was Aleva Neuro founded?

Aleva Neuro was founded in 2008.

Which sector is Aleva Neuro in?

Aleva Neuro operates in High Technology.

Who are Aleva Neuro's competitors?

Companies similar to Aleva Neuro include Circular Labs, Nanoleq, and LatticeFlow.